UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Form 10-Q
| (Mark One) | ||
|
þ
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
| For the period ended March 27, 2004 | ||
| or | ||
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
| For the transition period from to | ||
Commission file number: 1-16447
Maxtor Corporation
| Delaware | 77-0123732 | |
|
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
|
|
500 McCarthy Boulevard, Milpitas, CA (Address of principal executive offices) |
95035 (Zip Code) |
|
Registrants telephone number, including area code:
Indicate by checkmark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No o
Indicate by checkmark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act. Yes þ No o
As of April 29, 2004, 247,321,877 shares of the registrants Common Stock, $.01 par value, were issued and outstanding.
MAXTOR CORPORATION
FORM 10-Q
INDEX
1
PART I. FINANCIAL INFORMATION
| Item 1. | Condensed Consolidated Financial Statements (Unaudited) |
MAXTOR CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
| March 27, | December 27, | |||||||||
| 2004 | 2003 | |||||||||
| (Unaudited) | ||||||||||
| ASSETS | ||||||||||
|
Current assets:
|
||||||||||
|
Cash and cash equivalents
|
$ | 443,661 | $ | 530,816 | ||||||
|
Restricted cash
|
45,666 | 37,154 | ||||||||
|
Marketable securities
|
46,236 | 44,543 | ||||||||
|
Restricted marketable securities
|
41,930 | 42,337 | ||||||||
|
Accounts receivable, net of allowance of doubtful
accounts of $8,801 at March 27, 2004 and $11,220 at
December 27, 2003
|
471,846 | 540,943 | ||||||||
|
Other receivables
|
45,852 | 37,964 | ||||||||
|
Inventories
|
228,139 | 218,011 | ||||||||
|
Prepaid expenses and other
|
34,254 | 38,301 | ||||||||
|
Total current assets
|
1,357,584 | 1,490,069 | ||||||||
|
Property, plant and equipment, net
|
354,773 | 342,679 | ||||||||
|
Goodwill
|
813,951 | 813,951 | ||||||||
|
Other intangible assets, net
|
40,783 | 61,619 | ||||||||
|
Other assets
|
13,231 | 13,908 | ||||||||
|
Total assets
|
$ | 2,580,322 | $ | 2,722,226 | ||||||
| LIABILITIES AND STOCKHOLDERS EQUITY | ||||||||||
|
Current liabilities:
|
||||||||||
|
Short-term borrowings, including current portion
of long-term debt
|
$ | 22,045 | $ | 77,037 | ||||||
|
Accounts payable
|
694,977 | 730,056 | ||||||||
|
Accrued and other liabilities
|
367,981 | 454,388 | ||||||||
|
Liabilities of discontinued operations
|
807 | 1,487 | ||||||||
|
Total current liabilities
|
1,085,810 | 1,262,968 | ||||||||
|
Deferred taxes
|
196,455 | 196,455 | ||||||||
|
Long-term debt, net of current portion
|
377,840 | 355,809 | ||||||||
|
Other liabilities
|
181,580 | 186,485 | ||||||||
|
Total liabilities
|
1,841,685 | 2,001,717 | ||||||||
|
Stockholders equity:
|
||||||||||
|
Preferred stock, $0.01 par value,
95,000,000 shares authorized; no shares issued or
outstanding
|
| | ||||||||
|
Common stock, $0.01 par value,
525,000,000 shares authorized; 260,540,360 shares
issued and 247,294,622 shares outstanding at March 27,
2004 and 259,246,819 shares issued and
246,001,081 shares outstanding at December 27, 2003
|
2,605 | 2,592 | ||||||||
|
Additional paid-in capital
|
2,419,821 | 2,410,082 | ||||||||
|
Deferred stock-based compensation
|
| (110 | ) | |||||||
|
Accumulated deficit
|
(1,628,757 | ) | (1,637,920 | ) | ||||||
|
Cumulative other comprehensive income
|
9,907 | 10,804 | ||||||||
|
Treasury stock (13,245,738 shares) at cost
|
(64,939 | ) | (64,939 | ) | ||||||
|
Total stockholders equity
|
738,637 | 720,509 | ||||||||
|
Total liabilities and stockholders equity
|
$ | 2,580,322 | $ | 2,722,226 | ||||||
See accompanying notes to condensed consolidated financial statements.
2
MAXTOR CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
| Three Months Ended | ||||||||||
| March 27, 2004 | March 29, 2003 | |||||||||
| (Unaudited) | ||||||||||
|
Net revenues
|
1,019,688 | 938,889 | ||||||||
|
Cost of revenues
|
864,625 | 767,042 | ||||||||
|
Gross profit
|
155,063 | 171,847 | ||||||||
|
Operating expenses:
|
||||||||||
|
Research and development
|
84,770 | 86,661 | ||||||||
|
Selling, general and administrative
|
32,514 | 31,932 | ||||||||
|
Amortization of intangible assets
|
20,836 | 20,562 | ||||||||
|
Total operating expenses
|
138,120 | 139,155 | ||||||||
|
Income from operations
|
16,943 | 32,692 | ||||||||
|
Interest expense
|
(8,832 | ) | (5,422 | ) | ||||||
|
Interest income
|
1,288 | 1,208 | ||||||||
|
Other gain
|
38 | 207 | ||||||||
|
Income before income taxes
|
9,437 | 28,685 | ||||||||
|
Provision for income taxes
|
274 | 1,277 | ||||||||
|
Net income
|
$ | 9,163 | $ | 27,408 | ||||||
|
Net income per share basic
|
$ | 0.04 | $ | 0.11 | ||||||
|
Net income per share diluted
|
$ | 0.04 | $ | 0.11 | ||||||
|
Shares used in per share calculation
|
||||||||||
|
basic
|
246,590,255 | 243,634,139 | ||||||||
|
diluted
|
256,960,154 | 246,866,117 | ||||||||
See accompanying notes to condensed consolidated financial statements.
3
MAXTOR CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
| Three Months Ended | |||||||||||
| March 27, | March 29, | ||||||||||
| 2004 | 2003 | ||||||||||
| (Unaudited) | |||||||||||
| (In thousands) | |||||||||||
|
Cash Flows from Operating
Activities:
|
|||||||||||
|
Net income
|
$ | 9,163 | $ | 27,408 | |||||||
|
Adjustments to reconcile net income to net cash
provided by (used in) operating activities:
|
|||||||||||
|
Depreciation and amortization
|
36,107 | 41,942 | |||||||||
|
Amortization of intangible assets
|
20,836 | 20,562 | |||||||||
|
Stock-based compensation expense
|
144 | 273 | |||||||||
|
Loss on sale of property, plant and equipment and
other assets
|
353 | 2,308 | |||||||||
|
Gain on retirement of bond
|
| (111 | ) | ||||||||
|
Change in assets and liabilities:
|
|||||||||||
|
Accounts receivable
|
69,097 | 38,404 | |||||||||
|
Other receivables
|
(7,888 | ) | 5,015 | ||||||||
|
Inventories
|
(10,128 | ) | (41,528 | ) | |||||||
|
Prepaid expenses and other assets
|
3,910 | (8,992 | ) | ||||||||
|
Accounts payable
|
(32,177 | ) | (18,232 | ) | |||||||
|
Accrued and other liabilities
|
(91,312 | ) | (22,898 | ) | |||||||
|
Net cash provided by (used in) operating
activities from continuing operations
|
(1,895 | ) | 44,151 | ||||||||
|
Net cash flow used in discontinued operations
|
(680 | ) | (4,744 | ) | |||||||
|
Net cash provided by (used in) operating
activities
|
(2,575 | ) | 39,407 | ||||||||
|
Cash Flows from Investing
Activities:
|
|||||||||||
|
Proceeds from sale of property, plant and
equipment
|
720 | 103 | |||||||||
|
Purchase of property, plant and equipment
|
(52,176 | ) | (20,609 | ) | |||||||
|
Decrease (increase) in restricted cash
|
(8,512 | ) | 2,739 | ||||||||
|
Proceeds from sale of marketable securities
|
12,920 | 17,357 | |||||||||
|
Purchase of marketable securities
|
(14,289 | ) | (13,886 | ) | |||||||
|
Net cash used in investing activities
|
(61,337 | ) | (14,296 | ) | |||||||
|
Cash Flows from Financing
Activities:
|
|||||||||||
|
Proceeds from issuance of debt, including
short-term borrowings
|
24,655 | | |||||||||
|
Principal payments of debt including short-term
borrowings
|
(3,391 | ) | (4,622 | ) | |||||||
|
Principal payments under capital lease obligations
|
(4,225 | ) | (7,132 | ) | |||||||
|
Payment of receivable-backed borrowing
|
(50,000 | ) | | ||||||||
|
Proceeds from issuance of common stock from
employee stock purchase plan and stock options exercised
|
9,718 | 8,865 | |||||||||
|
Net cash used in financing activities
|
(23,243 | ) | (2,889 | ) | |||||||
|
Net change in cash and cash equivalents
|
(87,155 | ) | 22,222 | ||||||||
|
Cash and cash equivalents at beginning of period
|
530,816 | 306,444 | |||||||||
|
Cash and cash equivalents at end of period
|
$ | 443,661 | $ | 328,666 | |||||||
|
Supplemental Disclosures of Cash Flow
Information:
|
|||||||||||
|
Cash paid during the period for:
|
|||||||||||
|
Interest
|
$ | 4,168 | $ | 7,370 | |||||||
|
Income taxes
|
$ | 2,146 | $ | 1,551 | |||||||
|
Schedule of Non-Cash Investing and Financing
Activities:
|
|||||||||||
|
Purchase of property, plant and equipment
financed by accounts payable
|
$ | 2,966 | $ | 3,287 | |||||||
|
Retirement of debt in exchange for bond redemption
|
$ | 5,000 | $ | 5,000 | |||||||
|
Change in unrealized gain (loss) on investments
|
$ | (897 | ) | $ | 1,711 | ||||||
|
Purchase of property, plant and equipment
financed by capital lease obligations
|
$ | | $ | 2,826 | |||||||
The accompanying notes are an integral part of these financial statements.
4
MAXTOR CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
| 1. | Summary of Significant Accounting Policies |
| Basis of Presentation |
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. The consolidated financial statements include the accounts of Maxtor Corporation (Maxtor or the Company) and its wholly-owned subsidiaries. All significant intercompany transactions have been eliminated in consolidation. All adjustments of a normal recurring nature which, in the opinion of management, are necessary for a fair statement of the results for the interim periods have been made. The unaudited interim financial statements should be read in conjunction with the Companys audited consolidated financial statements and notes thereto for the fiscal year ended December 27, 2003 incorporated in the Companys Annual Report on Form 10-K. Interim results are not necessarily indicative of the operating results expected for later quarters or the full fiscal year.
| Use of Estimates |
The preparation of consolidated financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and reported amounts of revenues and expenses during the reporting periods. Actual results may differ from those estimates and such differences could be material.
| Recent Accounting Pronouncements |
In March 2004, the Emerging Issues Task Force (EITF) issued EITF Issue No. 03-6, Participating Securities and the Two-class Method Under FASB Statement No. 128, Earnings Per Share. EITF Issue No. 03-6 addresses a number of questions regarding the computation of earnings per share (EPS) by companies that have issued securities other than common stock that contractually entitle the holder to participate in dividends and earnings of the company when, and if, it declares dividends on its common stock. The issue also provides further guidance in applying the two-class method of calculating EPS. It clarifies what constitutes a participating security and how to apply the two-class method of computing EPS once it is determined that a security is participating, including how to allocate undistributed earnings to such a security. This pronouncement is effective for fiscal periods beginning after March 31, 2004. The Company is currently evaluating the provisions of EITF 03-6 to determine the impact, if any, on its computation of EPS.
| Stock-Based Compensation |
The Company accounts for non-cash stock-based employee compensation in accordance with APB Opinion No. 25 (APB 25), Accounting for Stock Issued to Employees and Related Interpretations, and complies with the disclosure provisions of Statement of Financial Accounting Standards No. 123 (SFAS 123), Accounting for Stock-Based Compensation and Statement of Financial Accounting Standard No. 148 (SFAS 148), Accounting for Stock-Based Compensation, Transition and Disclosures. The Company adopted FASB Interpretation No. 44 (FIN 44), Accounting for Certain Transactions Involving Stock Compensation, an Interpretation of APB 25 as of July 1, 2000. FIN 44 provides guidance on the application of APB 25 for non-cash stock-based compensation to employees. For fixed grants, under APB 25, compensation expense is based on the excess of the fair value of the Companys stock over the exercise price, if any, on the date of the grant and is recorded on a straight-line basis over the vesting period of the options, which is generally four years. For variable grants, compensation expense is based on changes in the fair value of the Companys stock and is recorded using the methodology set out in FASB Interpretation
5
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
No. 28 (FIN 28), Accounting for Stock Appreciation Rights and Other Variable Stock Option or Award Plans, an Interpretation of APB 15 and APB 25.
The Company accounts for non-cash stock-based compensation issued to non-employees in accordance with the provisions of SFAS 123 and Emerging Issues Task Force No. 96-18, Accounting for Equity Investments that are Issued to Non-Employees for Acquiring, or in Conjunction with Selling, Goods or Services.
The following pro forma net income (loss) information for Maxtors stock options and employee stock purchase plan has been prepared following the provisions of SFAS 123 (in thousands, except per share data):
| Three Months Ended | |||||||||
| March 27, | March 29, | ||||||||
| 2004 | 2003 | ||||||||
|
Net income applicable to common stockholders, as
reported
|
$ | 9,163 | $ | 27,408 | |||||
|
Add: Stock-based employee compensation expense
included in reported net income
|
144 | 273 | |||||||
|
Deduct: Total stock-based employee compensation
expense determined under fair value method for all awards
|
5,491 | 5,523 | |||||||
|
Pro forma net income
|
$ | 3,816 | $ | 22,158 | |||||
|
Net income per share
|
|||||||||
|
As reported basic
|
$ | 0.04 | $ | 0.11 | |||||
|
Pro forma basic
|
$ | 0.02 | $ | 0.09 | |||||
|
As reported diluted
|
$ | 0.04 | $ | 0.11 | |||||
|
Pro forma diluted
|
$ | 0.02 | $ | 0.09 | |||||
The fair value of option grants has been estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions:
| Three Months Ended | ||||||||
| March 27, | March 29, | |||||||
| 2004 | 2003 | |||||||
|
Risk-free interest rate
|
3.02 | % | 2.88 | % | ||||
|
Weighted average expected life
|
4.5 years | 4.5 years | ||||||
|
Volatility
|
75 | % | 75 | % | ||||
|
Dividend yield
|
| | ||||||
The fair value of employee stock purchase plan option grants has been estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions:
| Three Months Ended | ||||||||
| March 27, | March 29, | |||||||
| 2004 | 2003 | |||||||
|
Risk-free interest rate
|
1.01 | % | 1.12 | % | ||||
|
Weighted average expected life
|
0.5 years | 0.5 years | ||||||
|
Volatility
|
76 | % | 75 | % | ||||
|
Dividend yield
|
| | ||||||
No dividend yield is assumed as the Company has not paid dividends and has no plans to do so.
6
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
| Fiscal Calendar |
The Company operates and reports financial results on a fiscal year of 52 or 53 weeks ending on the last Saturday of December in each year. Accordingly, the three month periods ended March 27, 2004 comprised 13 weeks, as did the three months ended March 29, 2003. The current fiscal year ends on December 25, 2004. All references to years in these notes to consolidated financial statements represent fiscal years unless otherwise noted.
| 2. | Supplemental Financial Data |